Centessa Pharmaceuticals plc has filed an 8-K report on November 11, 2025, announcing an underwriting agreement to sell 11,627,907 American Depositary Shares at $21.50 each, potentially raising about $234.4 million. The funds will support product development and corporate purposes, and the sale may close by November 14, 2025.